ERIN WIESNER: Open Payments
NPI 1639493372 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,892 in 83 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $1,328 · 2025 $1,892
Food & beverage: $1,699Education: $193
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 24 | $514 |
| Daiichi Sankyo Inc. | 16 | $326 |
| Gilead Sciences, Inc. | 7 | $271 |
| Regeneron Healthcare Solutions, Inc. | 8 | $184 |
| Novartis Pharmaceuticals Corporation | 8 | $171 |
| Merck Sharp & Dohme LLC | 7 | $152 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $79 |
| AstraZeneca Pharmaceuticals LP | 2 | $53 |
| EMD Serono, Inc. | 2 | $42 |
| GlaxoSmithKline, LLC. | 1 | $24 |
Products named: Enhertu, DARZALEX, Trodelvy, KEYTRUDA, LIBTAYO, KISQALI, ERLEADA, ICLUSIG.
Industry payments across MO — which companies pay providers there.
